Everyday Care in Action: Thousands of Kenvue Employees Come Together Across 21 Markets to Help Advance Healthier Communities
Throughout the month of May, thousands of Kenvuers are coming together in 21 markets across six continents to support causes driven by the company's commitments, creating 5,000+ hours of meaningful moments, building stronger connections with their communities, and demonstrating the power of everyday care in action. This marks a fourfold increase in site participation compared to the program's inaugural year. This year, Kenvuers will help deliver approximately 22,000 hygiene kits, curated with over 110,000 products from across our iconic brands, including Neutrogena®, Listerine®, OGX®, Johnson's® Baby and Aveeno®, to support the health and wellbeing of vulnerable communities, including those affected by natural disasters, homelessness and conflict.
'Kenvue Cares Week is a powerful example of our Purpose – realize the extraordinary power of everyday care - in action. Our more than 20,000 Kenvuers share a passion for bringing everyday care to life for our consumers and communities and we are proud of the impact we are helping deliver,' said Russell Dyer, Chief Corporate Affairs Officer, Kenvue.
'Save the Children has been working for over 100 years to ensure all children have a healthy start in life, the opportunity to learn, and protection from harm," said Luciana Bonifacio, Chief Development Officer of Save the Children U.S. "We can't achieve this ambitious mission alone, and the support of strategic partners like Kenvue is essential for building lasting change for kids in the U.S. and around the world. This Kenvue Cares Week, we're proud to come together for a shared purpose—to make a difference for the wellbeing of children and communities in the aftermath of crises."
'Kenvue Cares Week presents the ideal opportunity to strengthen our mission at GRACE to care for our community through direct service. The sharing of personal care products plays an essential role in our efforts to support the underserved and help our neighbors take care of themselves,' said Amanda Block, Founder and Director, GRACE, a Summit based nonprofit focused on meeting the needs of underserved neighbors with community resources.
Advancing Healthy Communities
Examples of the activities Kenvuers will participate in include:
North America
Pack hygiene kits of Kenvue products for disaster relief with Heart to Heart International in the U.S. and with Save the Children in Canada.
Plant trees in Guelph and Markham, Canada, to support reforestation.
Distribute food with local partners GRACE and Bridges Outreach.
Pack food donations with the Mattie N. Dixon Community Cupboard in Fort Washington, Pennsylvania.
Latin America:
Build hygiene kits with Save the Children in Cali, Colombia and Mexico City, Mexico, and with Direct Relief in Sao Paulo and San Jose Dos Campos, Brazil.
Build sanitary bathrooms and help promote hygiene habits with local partner Modulo Sanitario in Buenos Aires, Argentina.
Renovate playgrounds at children's villages with Aldeas Infantiles in Asunción, Paraguay.
Europe, Middle East, and Africa:
Pack hygiene kits with Save the Children in Cape Town, South Africa; Spain, Madrid, and with In Kind Direct in high Wycombe, England.
Participate in "plogging" (jogging and picking up litter at the same time) in Rotkreuz, Switzerland Host an Equity in STEM workshop in High Wycombe, England.
Asia-Pacific:
Assemble hygiene kits with Save the Children in Sydney, Australia, Beijing, and Shanghai, China.
Plant trees on Motuihe Island in Auckland, New Zealand.
Support elderly care centers in Singapore through NTUC Health Day Care Centre.
Pack food kits with the India Food Banking Network in Baddi and Mulund, India.
About Kenvue
Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
Cautions Concerning Forward-Looking Statements
This press release contains 'forward-looking statements' as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, statements about management's expectations of Kenvue's future operating and financial performance, product development, market position and business strategy. Forward-looking statements may be identified by the use of words such as 'plans,' 'expects,' 'will,' 'anticipates,' 'estimates' and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates. A list and descriptions of these risks, uncertainties and other factors can be found in Kenvue's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Any forward-looking statement made in this release speaks only as of the date of this release. Kenvue undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Centene's (NYSE:CNC) Q2 Sales Beat Estimates But Stock Drops 12.2%
Health coverage company Centene (NYSE:CNC) reported Q2 CY2025 results topping the market's revenue expectations , with sales up 22.4% year on year to $48.74 billion. Its non-GAAP loss of $0.16 per share was significantly below analysts' consensus estimates. Is now the time to buy Centene? Find out in our full research report. Centene (CNC) Q2 CY2025 Highlights: Lower payments from the government, higher medical costs, more expensive care for Medicaid members Revenue: $48.74 billion vs analyst estimates of $43.67 billion (22.4% year-on-year growth, 11.6% beat) Adjusted EPS: -$0.16 vs analyst estimates of $0.23 (significant miss) Adjusted EBITDA: -$282 million vs analyst estimates of $91.23 million (-0.6% margin, significant miss) Operating Margin: -0.9%, down from 3.1% in the same quarter last year Free Cash Flow Margin: 3.2%, down from 5% in the same quarter last year Customers: 28 million, up from 27.94 million in the previous quarter Market Capitalization: $13.32 billion "We are disappointed by our second quarter results, but we have a clear understanding of the trends that have impacted our performance, and are working with urgency and focus to restore our earnings trajectory," said Chief Executive Officer of Centene, Sarah M. London. Company Overview Serving nearly 1 in 15 Americans through its government healthcare programs, Centene (NYSE:CNC) is a healthcare company that manages government-sponsored health insurance programs like Medicaid and Medicare for low-income and complex-needs populations. Revenue Growth Examining a company's long-term performance can provide clues about its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Luckily, Centene's sales grew at a solid 14.2% compounded annual growth rate over the last five years. Its growth beat the average healthcare company and shows its offerings resonate with customers, a helpful starting point for our analysis. Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Centene's annualized revenue growth of 9.8% over the last two years is below its five-year trend, but we still think the results were respectable. Centene also reports its number of customers, which reached 28 million in the latest quarter. Over the last two years, Centene's customer base averaged 1.2% year-on-year growth. Because this number is lower than its revenue growth, we can see the average customer spent more money each year on the company's products and services. This quarter, Centene reported robust year-on-year revenue growth of 22.4%, and its $48.74 billion of revenue topped Wall Street estimates by 11.6%. Looking ahead, sell-side analysts expect revenue to remain flat over the next 12 months, a deceleration versus the last two years. This projection doesn't excite us and suggests its products and services will see some demand headwinds. At least the company is tracking well in other measures of financial health. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Operating Margin Centene's operating margin might fluctuated slightly over the last 12 months but has generally stayed the same, averaging 1.5% over the last five years. This profitability was lousy for a healthcare business and caused by its suboptimal cost structure. Analyzing the trend in its profitability, Centene's operating margin might fluctuated slightly but has generally stayed the same over the last five years. This raises questions about the company's expense base because its revenue growth should have given it leverage on its fixed costs, resulting in better economies of scale and profitability. This quarter, Centene's breakeven margin was down 4 percentage points year on year. This contraction shows it was less efficient because its expenses grew faster than its revenue. Earnings Per Share Revenue trends explain a company's historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions. Centene's flat EPS over the last five years was below its 14.2% annualized revenue growth. However, its operating margin didn't change during this time, telling us that non-fundamental factors such as interest and taxes affected its ultimate earnings. In Q2, Centene reported EPS at negative $0.16, down from $2.42 in the same quarter last year. This print missed analysts' estimates. Over the next 12 months, Wall Street expects Centene's full-year EPS of $5.16 to shrink by 24.8%. Key Takeaways from Centene's Q2 Results We liked that Centene beat analysts' revenue expectations this quarter. On the other hand, EPS missed significantly due to lower payments from the government, higher medical costs, more expensive care for Medicaid members. Management called the results "disappointing" and are addressing the issues in the business. Shares traded down 12.2% to $23.51 immediately following the results. Is Centene an attractive investment opportunity at the current price? If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
39 minutes ago
- Yahoo
Kellanova Declares Regular Dividend of $0.58 per Share for Third Quarter
CHICAGO, July 25, 2025 /PRNewswire/ -- Kellanova (NYSE: K) today announced that its Board of Directors declared a dividend of $0.58 per share on the common stock of Kellanova, payable on September 15, 2025, to shareowners of record at the close of business on is September 2, 2025. The ex-dividend date is September 2, 2025. This is the 403rd dividend that Kellanova has paid to owners of common stock since 1925 and is a one cent increase from its previous quarterly rate. About Kellanova Kellanova (NYSE: K) is a leader in global snacking, international cereal and noodles, and North America frozen foods with a legacy stretching back more than 100 years. Powered by differentiated brands including Pringles®, Cheez-It®, Pop-Tarts®, Kellogg's ® Rice Krispies Treats®, RXBAR®, Eggo®, MorningStar Farms®, Special K®, Coco Pops®, and more, Kellanova's vision is to become the world's best-performing snacks-led powerhouse, unleashing the full potential of our differentiated brands and our passionate people. Our net sales for 2024 were approximately $13 billion. At Kellanova, our purpose is to create better days and ensure everyone has a seat at the table through our trusted food brands. We are committed to promoting sustainable and equitable food access by tackling the crossroads of hunger, sustainability, wellbeing, and equity, diversity & inclusion. Our goal is to create Better Days for 4 billion people by the end of 2030 (from a 2015 baseline). For more detailed information about our commitments, our approach to achieving these goals, and methodology, please visit our website at [K-DIV] [K-FIN] View original content to download multimedia: SOURCE Kellanova IR Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
40 minutes ago
- Business Wire
Securities Fraud Investigation Into Barnes & Noble Education, Inc. (BNED) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Barnes & Noble Education, Inc. ('Barnes & Noble' or the 'Company') (NYSE: BNED) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BARNES & NOBLE EDUCATION, INC. (BNED), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On July 18, 2025, Barnes & Noble disclosed that '[c]ertain information regarding the recording of cost of digital sales was brought to the attention of management' and that, as a result, 'management believes that the Company may have a potential overstatement of up to $23.0 million in the aggregate to its accounts receivable balance as of its May 3, 2025 fiscal year-end.' On this news, Barnes & Noble's stock price fell $2.36, or 21%, to close at $8.87 per share on July 21, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Charles Linehan, Esq. Glancy Prongay & Murray LLP 1925 Century Park East, Suite 2100 Los Angeles California 90067 Email: shareholders@ Telephone: 310-201-9150 (Toll-Free: 888-773-9224) Visit our website at Follow us for updates on LinkedIn, Twitter, or Facebook. Whistleblower Notice Persons with non-public information regarding Barnes & Noble should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email shareholders@ About Glancy Prongay & Murray LLP Glancy Prongay & Murray LLP ('GPM') is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. GPM has been consistently ranked in the Top 50 Securities Class Action Settlements by ISS Securities Class Action Services. In 2018, GPM was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements. With four offices across the country, GPM's nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPM's lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPM's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
